Global compound status map / 42 countries

PT-141 / Bremelanotide
by country.

This global guide resolves PT-141 / Bremelanotide to its us research-market identity with a separate fda-approved medicine record first, then connects that identity to 42 country guides across five regions. Each country card opens the official product and seller or supply records that must be checked before any claim about approval, availability, legality, or a vendor can be supported.

Choose your evidence route

Four useful next steps for PT-141 / Bremelanotide.

Start with the question you actually need answered. Each route keeps the PT-141 / Bremelanotide identity, official trial record, destination status, and comparison dataset separate.

Fast destination lookup

Choose one country. Open the right records.

Skip the full atlas when you already know the destination. The result keeps the compound identity, national product record, and seller or supply record separate.

42-country source routerPT-141 / Bremelanotide / exact destination
Region
North America
Language
English
Reviewed
July 18, 2026
Exact country answer

PT-141 / Bremelanotide in the United States

VYLEESI is an FDA-approved bremelanotide prescription product under NDA 210557 with a 1.75 mg autoinjector presentation and product-specific label. The 10 mg PT-141 research listings tracked here are not VYLEESI and do not inherit its approval or regulated supply chain.

Evidence lane
Research price board
Global identity
US research-market identity with a separate FDA-approved medicine record
Live decision workspace

Compare PT-141 / Bremelanotide with VYLEESI, without losing the country context.

Put evidence status, ClinicalTrials.gov coverage, official United States records, and qualified US research prices in one view. Blank fields stay blank when the underlying dataset does not support a number.

Open this comparison Choose any two records
AIdentity record
PT-141 / Bremelanotide

US research-market identity with a separate FDA-approved medicine record

3 dated seller rows
Destination fixedUnited StatesNorth America

Official product and seller records attached

BComparison record
VYLEESI

Product-specific FDA-approved US medicine record

No linked research price board
01 · Status02 · Trials03 · Country04 · Price
Worldwide status answer

No one-word global verdict.

This record resolves seller-labelled 10 mg PT-141 research listings. VYLEESI is a separate FDA-approved bremelanotide prescription product with a 1.75 mg presentation, defined indication, label, and regulated supply chain. The research listings do not inherit that approval.

Primary identity source: Read the current DailyMed drug label / National Library of Medicine, DailyMed
Direct answers

The questions behind a worldwide search.

These answers define the evidence boundary. They do not provide medical or legal advice, a seller recommendation, or a country-wide availability claim.

01

Is PT-141 / Bremelanotide legal or available in every country?

No. PT-141 / Bremelanotide is mapped here from a US research-market identity. A research label does not establish that the material is authorized, lawfully supplied, or available in another country. Use the exact national product, seller, pharmacy, and supply records below.

02

Can an online listing prove PT-141 / Bremelanotide's local status?

No. A page using the name PT-141 / Bremelanotide, a local currency, domestic delivery language, or a familiar vial image is only a lead. It does not prove the exact product identity, local authorization, current supply status, pharmacy or establishment license, import route, or seller authority.

03

What should I check before comparing PT-141 / Bremelanotide suppliers?

Resolve PT-141 / Bremelanotide through its primary identity record first. Then open the destination country's product database and its separate seller, pharmacy, establishment, or supply record. Compare offers only when the category, legal seller identity, exact presentation, delivery market, price, and source date all match.

Comparison method

Identity first. Country second. Seller third.

The same sequence works worldwide while the responsible authority, terminology, records, and available supply routes change by destination.

01

Resolve the exact name

Use the primary identity record for PT-141 / Bremelanotide, including aliases and the correct research, clinical-pipeline, or medicine evidence lane.

02

Choose the destination

Open the country guide and match the exact product, presentation, current status, authorization holder, and supply route in the national record.

03

Verify the seller separately

Resolve the legal seller, pharmacy, clinic, establishment, or importer in the applicable official register before comparing a claim, price, or delivery route.

Five world regions

Start broad, then land on the country record.

Each regional summary preserves the compound’s evidence lane and links to every maintained national verification route in that part of the world.

0116 country guides

PT-141 / Bremelanotide in Europe

PT-141 / Bremelanotide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

025 country guides

PT-141 / Bremelanotide in Latin America

PT-141 / Bremelanotide in Latin America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

0314 country guides

PT-141 / Bremelanotide in Asia-Pacific

PT-141 / Bremelanotide in Asia-Pacific is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

042 country guides

PT-141 / Bremelanotide in North America

PT-141 / Bremelanotide in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

055 country guides

PT-141 / Bremelanotide in Middle East and Africa

PT-141 / Bremelanotide in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

Europe / 16 destinations

PT-141 / Bremelanotide in Europe.

PT-141 / Bremelanotide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

01
FranceFrançais / updated 18 juillet 2026

PT-141 / Bremelanotide en France

PT-141 / Bremelanotide est suivi comme identité du marché américain de la recherche, et non comme preuve d’autorisation ou d’approvisionnement local en France. Vérifiez la catégorie exacte, l’identité juridique du vendeur et le circuit revendiqué dans les registres officiels de cette page.

02
United KingdomEnglish / updated July 18, 2026

PT-141 / Bremelanotide in the United Kingdom

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for the United Kingdom. Match the exact category, legal seller identity, and claimed route against the official records on this page.

03
DeutschlandDeutsch / updated 18. Juli 2026

PT-141 / Bremelanotide in Deutschland

PT-141 / Bremelanotide wird als Identität im US-Forschungsmarkt geführt, nicht als Nachweis einer Zulassung oder lokalen Versorgung in Deutschland. Prüfe die genaue Kategorie, die rechtliche Anbieteridentität und den behaupteten Bezugsweg in den amtlichen Registern dieser Seite.

04
EspañaEspañol / updated 18 de julio de 2026

PT-141 / Bremelanotide en España

PT-141 / Bremelanotide se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en España. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página.

05
ItaliaItaliano / updated 18 luglio 2026

PT-141 / Bremelanotide in Italia

The 10 mg PT-141 research listings tracked here are not the US VYLEESI prescription product and do not inherit its FDA approval. AIFA states that a medicinal product must have marketing authorization from AIFA or the European Commission before it can be marketed in Italy. The linked Italian records must be searched for the exact product and presentation. They do not establish that a same-name online vial is authorized, available, lawful, or equivalent to VYLEESI.

06
NederlandNederlands / updated 18 juli 2026

PT-141 / Bremelanotide in Nederland

PT-141 / Bremelanotide wordt gevolgd als identiteit op de Amerikaanse onderzoeksmarkt, niet als bewijs van toelating of lokale levering in Nederland. Controleer de exacte categorie, juridische identiteit van de aanbieder en opgegeven route in de officiële registers op deze pagina.

07
SwitzerlandEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Switzerland

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page.

08
PolskaPolski / updated 18 lipca 2026

PT-141 / Bremelanotide w Polsce

PT-141 / Bremelanotide jest tu identyfikatorem z amerykańskiego rynku badawczego, a nie dowodem dopuszczenia lub lokalnej dostawy w Polsce. Sprawdź dokładną kategorię, prawną tożsamość sprzedawcy i deklarowaną drogę w urzędowych rejestrach na tej stronie.

09
IrelandEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Ireland

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Ireland. Match the exact category, legal seller identity, and claimed route against the official records on this page.

10
PortugalPortuguês (Portugal) / updated 18 de julho de 2026

PT-141 / Bremelanotide em Portugal

PT-141 / Bremelanotide é acompanhado como identidade do mercado de investigação dos EUA, não como prova de autorização ou fornecimento local em Portugal. Compare a categoria exata, a identidade jurídica do vendedor e a via alegada com os registos oficiais desta página.

11
SverigeSvenska / updated 18 juli 2026

PT-141 / Bremelanotide i Sverige

PT-141 / Bremelanotide följs som en identitet på den amerikanska forskningsmarknaden, inte som bevis på godkännande eller lokal leverans i Sverige. Kontrollera exakt kategori, säljarens juridiska identitet och den påstådda vägen i de officiella registren på sidan.

12
TürkiyeTürkçe / updated 18 Temmuz 2026

Türkiye için PT-141 / Bremelanotide

PT-141 / Bremelanotide, ABD araştırma pazarında kullanılan bir kimlik olarak izlenir; Türkiye için ruhsat, yasal tedarik veya gerçek bulunabilirlik kanıtı değildir. Ürün sınıfını, satıcının hukuki kimliğini, güncel faaliyet durumunu ve iddia edilen tedarik yolunu bu sayfadaki resmi ürün ve kuruluş kayıtlarında ayrı ayrı eşleştirin.

13
ÖsterreichDeutsch / updated 18. Juli 2026

PT-141 / Bremelanotide in Österreich

PT-141 / Bremelanotide wird als Identität im US-Forschungsmarkt geführt, nicht als Nachweis einer Zulassung oder lokalen Versorgung in Österreich. Prüfe die genaue Kategorie, die rechtliche Anbieteridentität und den behaupteten Bezugsweg in den amtlichen Registern dieser Seite.

14
BelgiëNederlands / updated 18 juli 2026

PT-141 / Bremelanotide in België

PT-141 / Bremelanotide wordt gevolgd als identiteit op de Amerikaanse onderzoeksmarkt, niet als bewijs van toelating of lokale levering in België. Controleer de exacte categorie, juridische identiteit van de aanbieder en opgegeven route in de officiële registers op deze pagina.

15
DanmarkDansk / updated 18. juli 2026

PT-141 / Bremelanotide i Danmark

PT-141 / Bremelanotide følges som en identitet på det amerikanske forskningsmarked, ikke som dokumentation for godkendelse, lovlig forsyning eller faktisk tilgængelighed i Danmark. Sammenhold produktkategori, sælgerens juridiske identitet, aktuel registerstatus og den påståede forsyningsvej med de separate officielle registre på denne side.

16
SuomiSuomi / updated 18. heinäkuuta 2026

PT-141 / Bremelanotide kohteessa Suomi

PT-141 / Bremelanotide seurataan Yhdysvaltain tutkimusmarkkinassa käytettynä identiteettinä, ei todisteena hyväksynnästä, laillisesta toimituksesta tai todellisesta saatavuudesta kohteessa Suomi. Vertaa tuoteluokka, myyjän oikeudellinen identiteetti, nykyinen rekisteritila ja väitetty toimitusreitti erikseen tämän sivun virallisiin rekistereihin.

Latin America / 5 destinations

PT-141 / Bremelanotide in Latin America.

PT-141 / Bremelanotide in Latin America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

01
MéxicoEspañol / updated 18 de julio de 2026

PT-141 / Bremelanotide en México

PT-141 / Bremelanotide se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en México. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página.

02
ArgentinaEspañol / updated 18 de julio de 2026

PT-141 / Bremelanotide en Argentina

PT-141 / Bremelanotide se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Argentina. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página.

03
ColombiaEspañol / updated 18 de julio de 2026

PT-141 / Bremelanotide en Colombia

PT-141 / Bremelanotide se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Colombia. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página.

04
ChileEspañol / updated 18 de julio de 2026

PT-141 / Bremelanotide en Chile

PT-141 / Bremelanotide se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Chile. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página.

05
BrasilPortuguês (Brasil) / updated 18 de julho de 2026

PT-141 / Bremelanotide no Brasil

PT-141 / Bremelanotide é acompanhado como identidade do mercado de pesquisa dos EUA, não como prova de autorização ou fornecimento local no Brasil. Compare a categoria exata, a identidade jurídica do vendedor e a rota alegada com os registros oficiais desta página.

Asia-Pacific / 14 destinations

PT-141 / Bremelanotide in Asia-Pacific.

PT-141 / Bremelanotide in Asia-Pacific is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

01
中国简体中文 / updated 2026年7月18日

PT-141 / Bremelanotide 在中国的状态与官方记录

PT-141 / Bremelanotide在此仅作为美国科研市场中的名称身份跟踪,并不是其在中国获批、合法供应或实际可得的证明。必须通过本页链接的官方记录,分别核对具体类别、产品信息、法律经营主体、登记状态与声称的供应路径,不能让科研标签继承药品批准或临床项目证据。

02
AustraliaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Australia

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Australia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

03
New ZealandEnglish / updated July 18, 2026

PT-141 / Bremelanotide in New Zealand

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for New Zealand. Match the exact category, legal seller identity, and claimed route against the official records on this page.

04
IndiaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in India

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for India. Match the exact category, legal seller identity, and claimed route against the official records on this page.

05
日本日本語 / updated 2026年7月18日

日本のPT-141 / Bremelanotide

PT-141 / Bremelanotideは米国の研究市場で使われる名称として追跡しており、日本での承認、合法な供給、実際の入手可能性を示すものではありません。このページの公的記録で、製品区分、販売主体の法的名称、現在の登録状態、主張される供給経路を個別に照合してください。

06
대한민국한국어 / updated 2026년 7월 18일

대한민국의 PT-141 / Bremelanotide

PT-141 / Bremelanotide은 미국 연구 시장에서 사용되는 명칭으로 추적되며, 대한민국에서의 허가, 합법적 공급 또는 실제 이용 가능성을 의미하지 않습니다. 이 페이지의 공식 기록에서 정확한 제품 유형, 판매 주체의 법적 신원, 현재 등록 상태와 주장된 공급 경로를 각각 대조하세요.

07
ประเทศไทยไทย / updated 18 กรกฎาคม 2569

PT-141 / Bremelanotide ในประเทศไทย

PT-141 / Bremelanotide ถูกติดตามในฐานะชื่อที่ใช้ในตลาดวัสดุวิจัยของสหรัฐฯ ไม่ใช่หลักฐานการอนุมัติ การจัดหาโดยชอบด้วยกฎหมาย หรือความพร้อมขายจริงในประเทศไทย ต้องเทียบประเภทผลิตภัณฑ์ นิติบุคคลของผู้ขาย สถานะทะเบียนปัจจุบัน และเส้นทางการจัดหาที่อ้างกับบันทึกทางการในหน้านี้

08
IndonesiaBahasa Indonesia / updated 18 Juli 2026

PT-141 / Bremelanotide di Indonesia

PT-141 / Bremelanotide dilacak sebagai identitas yang digunakan di pasar riset Amerika Serikat, bukan sebagai bukti persetujuan, pasokan yang legal, atau ketersediaan nyata di Indonesia. Cocokkan kategori produk, identitas hukum penjual, status catatan terkini, dan jalur pasok yang diklaim dengan catatan resmi di halaman ini.

09
SingaporeEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Singapore

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Singapore. Match the exact category, legal seller identity, and claimed route against the official records on this page.

10
PhilippinesEnglish / updated July 18, 2026

PT-141 / Bremelanotide in the Philippines

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for the Philippines. Match the exact category, legal seller identity, and claimed route against the official records on this page.

11
MalaysiaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Malaysia

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page.

12
台灣繁體中文(台灣) / updated 2026年7月18日

PT-141 / Bremelanotide 在台灣的紀錄

PT-141 / Bremelanotide在此僅作為美國研究市場名稱追蹤,不能證明其在台灣獲准、合法供應或實際可得。請在本頁官方紀錄中分別核對產品類別、許可證資料、賣方或機構法律身分、目前狀態與宣稱的供應途徑,研究用途標示不能承接藥品許可。

13
香港繁體中文(香港) / updated 2026年7月18日

PT-141 / Bremelanotide 在香港的紀錄

PT-141 / Bremelanotide在此只作為美國研究市場名稱追蹤,不能證明其在香港已註冊、合法供應或實際可得。請在本頁官方紀錄中分別核對產品類別、註冊資料、銷售商法定身分、牌照狀態和聲稱的供應途徑,研究用途標籤不能承接藥劑製品註冊。

14
Việt NamTiếng Việt / updated 18 tháng 7 năm 2026

PT-141 / Bremelanotide tại Việt Nam

PT-141 / Bremelanotide được theo dõi như một danh tính trên thị trường nghiên cứu Hoa Kỳ, không phải bằng chứng về giấy phép, nguồn cung hợp pháp hay khả năng có hàng tại Việt Nam. Hãy đối chiếu riêng loại sản phẩm, pháp nhân người bán, tình trạng hồ sơ hiện hành và đường cung ứng được tuyên bố trong các nguồn chính thức trên trang này.

North America / 2 destinations

PT-141 / Bremelanotide in North America.

PT-141 / Bremelanotide in North America is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

01
United StatesEnglish / updated July 18, 2026

PT-141 / Bremelanotide in the United States

VYLEESI is an FDA-approved bremelanotide prescription product under NDA 210557 with a 1.75 mg autoinjector presentation and product-specific label. The 10 mg PT-141 research listings tracked here are not VYLEESI and do not inherit its approval or regulated supply chain.

02
CanadaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Canada

Health Canada records PT-141 among unauthorized injectable peptide products seized in Calgary. That record does not authenticate every same-name listing and does not transfer the identity or approval of the US VYLEESI prescription product to a research vial.

Middle East and Africa / 5 destinations

PT-141 / Bremelanotide in Middle East and Africa.

PT-141 / Bremelanotide in Middle East and Africa is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.

01
الإمارات العربية المتحدةالعربية / updated 18 يوليو 2026

PT-141 / بريميلانوتايد في الإمارات العربية المتحدة

يتم تتبع PT-141 / بريميلانوتايد هنا كهوية مستخدمة في سوق الأبحاث الأمريكي، وليس كدليل على الترخيص أو التوريد المحلي في الإمارات العربية المتحدة. يجب مطابقة الفئة المحددة والهوية القانونية للبائع ومسار التوريد المعلن مع سجلات المنتج والمنشأة الرسمية في هذه الصفحة قبل استنتاج التوفر أو المشروعية.

02
المملكة العربية السعوديةالعربية / updated 18 يوليو 2026

PT-141 / بريميلانوتايد في المملكة العربية السعودية

يتم تتبع PT-141 / بريميلانوتايد هنا كهوية مستخدمة في سوق الأبحاث الأمريكي، وليس كدليل على الترخيص أو التوريد المحلي في المملكة العربية السعودية. يجب مطابقة الفئة المحددة والهوية القانونية للبائع ومسار التوريد المعلن مع سجلات المنتج والمنشأة الرسمية في هذه الصفحة قبل استنتاج التوفر أو المشروعية.

03
South AfricaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in South Africa

SAHPRA names PT-141 among peptide products unlawfully marketed in South Africa and states that products intended to treat, prevent, or alter bodily functions must be registered before sale. That guidance does not authenticate a specific online listing or seller.

04
NigeriaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Nigeria

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Nigeria. Match the exact category, legal seller identity, and claimed route against the official records on this page.

05
KenyaEnglish / updated July 18, 2026

PT-141 / Bremelanotide in Kenya

PT-141 / Bremelanotide is tracked as a US research-market identity, not as an authorization or local supply finding for Kenya. Match the exact category, legal seller identity, and claimed route against the official records on this page.

Audit the work

Every conclusion stays attached to a source route.

The compound identity source is linked above. Every country card links its national product and seller or supply records, then opens a localized guide with the full verification boundary.

Open the PT-141 / Bremelanotide identity record →Compare PT-141 / Bremelanotide across 50 US states →Compare PT-141 / Bremelanotide across 10 Canadian provinces →Download all 1722 compound-country rows →Download all 2050 compound-state rows →Download all 410 compound-province rows →Audit the regional access dataset →Review the complete source registry →Read the publication standard →